Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specification
| Brand name | METOPROLOL SUCCINATE |
| Generic name | METOPROLOL SUCCINATE ER TABLETS |
| Active ingredient(s) | METOPROLOL SUCCINATE |
| Distributed by / for | Ascend Laboratories, LLC, Parsippany NJ 07054 |
| NDC | 67877-591-05 |
| Full product label | Metoprolol Succinate Extended-Release Tablets, USP 50 mg, Rx Only, 500 Tablets per bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC, Parsippany NJ 07054, NDC 67877-591-05. |
| Recalling firm | Ascend Laboratories, LLC |
| Distribution | Nationwide and Puerto Rico |
| Quantity | 2628 bottles |
| Recall initiated | 2023-01-05 |
| Report date | 2023-02-01 |
| Recall completed | 2024-08-15 |
| Recall number | D-0171-2023 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Parsippany NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗